Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Does anyone think that Merck's recent announcement could be good for us here? I'm thinking that any big pharmas that are aware of apabetalone and it's possibilities might want to make their move now, if they haven't already.
It's wishful thinking I know but I'm curious what others think.
